FR2852959B1 - Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives - Google Patents

Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives

Info

Publication number
FR2852959B1
FR2852959B1 FR0303899A FR0303899A FR2852959B1 FR 2852959 B1 FR2852959 B1 FR 2852959B1 FR 0303899 A FR0303899 A FR 0303899A FR 0303899 A FR0303899 A FR 0303899A FR 2852959 B1 FR2852959 B1 FR 2852959B1
Authority
FR
France
Prior art keywords
solubilizing
preparation
active substances
pharmacologically active
cyclodextrin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0303899A
Other languages
English (en)
French (fr)
Other versions
FR2852959A1 (fr
Inventor
Jacques Defaye
Mellet Carmen Ortiz
Fernandez Jose Manuel Garcia
Kazimierz Chmurski
Jian Xin Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Joseph Fourier University
Original Assignee
Centre National de la Recherche Scientifique
Joseph Fourier University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0303899A priority Critical patent/FR2852959B1/fr
Application filed by Centre National de la Recherche Scientifique, Joseph Fourier University filed Critical Centre National de la Recherche Scientifique
Priority to ES04742303T priority patent/ES2338558T3/es
Priority to EP04742303A priority patent/EP1608687B1/fr
Priority to CA2520391A priority patent/CA2520391C/fr
Priority to DE602004025213T priority patent/DE602004025213D1/de
Priority to JP2006505741A priority patent/JP5054970B2/ja
Priority to US10/551,343 priority patent/US7632941B2/en
Priority to PCT/FR2004/000691 priority patent/WO2004087768A1/fr
Priority to AT04742303T priority patent/ATE455795T1/de
Publication of FR2852959A1 publication Critical patent/FR2852959A1/fr
Application granted granted Critical
Publication of FR2852959B1 publication Critical patent/FR2852959B1/fr
Priority to US12/468,356 priority patent/US8440814B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR0303899A 2003-03-28 2003-03-28 Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives Expired - Fee Related FR2852959B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0303899A FR2852959B1 (fr) 2003-03-28 2003-03-28 Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives
AT04742303T ATE455795T1 (de) 2003-03-28 2004-03-22 Neue cyclodextrinderivate, herstellungsverfahren dafür und verwendung davon zur solubilisierung von pharmakologisch wirksamen substanzen
CA2520391A CA2520391C (fr) 2003-03-28 2004-03-22 Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour la solubilisation de substances pharmacologiquement actives
DE602004025213T DE602004025213D1 (de) 2003-03-28 2004-03-22 Neue cyclodextrinderivate, herstellungsverfahren dafür und verwendung davon zur solubilisierung von pharmakologisch wirksamen substanzen
JP2006505741A JP5054970B2 (ja) 2003-03-28 2004-03-22 新規なシクロデキストリン誘導体、それらの製造方法、および薬理学的に活性な物質を可溶化するためのそれらの使用
US10/551,343 US7632941B2 (en) 2003-03-28 2004-03-22 Cyclodextrin derivatives, method for the preparation thereof and use thereof for the solubilization of pharmacologically active substances
ES04742303T ES2338558T3 (es) 2003-03-28 2004-03-22 Nuevos derivados de ciclodextrinas, su procedimiento de preparacion y su utilizacion en particular para la solubilizacion de sustancias farmacologicamente activas.
EP04742303A EP1608687B1 (fr) 2003-03-28 2004-03-22 Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour la solubilisation de substances pharmacologiquement actives
PCT/FR2004/000691 WO2004087768A1 (fr) 2003-03-28 2004-03-22 Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour la solubilisation de substances pharmacologiquement actives
US12/468,356 US8440814B2 (en) 2003-03-28 2009-05-19 Derivatives of cyclodextrins, process for their preparation and their use in particular for solubilizing pharmacologically active substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0303899A FR2852959B1 (fr) 2003-03-28 2003-03-28 Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives

Publications (2)

Publication Number Publication Date
FR2852959A1 FR2852959A1 (fr) 2004-10-01
FR2852959B1 true FR2852959B1 (fr) 2008-02-15

Family

ID=32947275

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0303899A Expired - Fee Related FR2852959B1 (fr) 2003-03-28 2003-03-28 Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives

Country Status (9)

Country Link
US (2) US7632941B2 (enExample)
EP (1) EP1608687B1 (enExample)
JP (1) JP5054970B2 (enExample)
AT (1) ATE455795T1 (enExample)
CA (1) CA2520391C (enExample)
DE (1) DE602004025213D1 (enExample)
ES (1) ES2338558T3 (enExample)
FR (1) FR2852959B1 (enExample)
WO (1) WO2004087768A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080234182A1 (en) * 2007-03-22 2008-09-25 Innovative Biologics, Inc. Blockers of pore-forming virulence factors and their use as anti-infectives
EP1735326A4 (en) * 2004-01-29 2011-04-20 Pinnacle Pharmaceuticals BETA-CYCLODEXTRIN DERIVATIVES AND THEIR USE AGAINST LETHAL ANTHRAX TOXIN
AU2005240122B2 (en) 2004-05-03 2011-02-17 Omega Bio-Pharma (I.P.3) Limited Cysteamines for treating complications of hypercholesterolemia and diabetes
CN101151037A (zh) 2005-01-28 2008-03-26 平纳克尔医药股份有限公司 作为抗菌剂的β-环糊精衍生物
ES2294926B1 (es) * 2006-05-11 2009-02-16 Universidad De Sevilla Nuevos derivados de ciclodextrinas selectivamente funcionalizados en su cara secundaria, procedimiento de preparacion y utilizacion de los mismos.
FR2903987B1 (fr) * 2006-07-21 2012-12-21 Centre Nat Rech Scient Nouveaux derives de cyclodextrines amphiphiles, leur utilisation dans les domaines pharmaceutiques,cosmetiques, alimentaires et leur application a la production de nouveaux nanosystemes
US8592611B2 (en) * 2008-07-17 2013-11-26 The Johns Hopkins University Trioxane dimer sulfur compounds
WO2010017328A2 (en) * 2008-08-06 2010-02-11 Rgo Biosciences Llc Cyclodextrin conjugates
WO2015179963A1 (en) 2014-05-29 2015-12-03 Uti Limited Partnership Cyclodextrin-based polyanionic and non-ionic dendrimers
CN109762042B (zh) * 2018-09-21 2022-04-08 河北艾克美冀生物科技有限公司 一种治疗癌症的药物、其合成方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2648464B1 (fr) * 1989-06-14 1991-08-30 Commissariat Energie Atomique Derives de cyclomalto-oligosaccharides et leurs procedes de preparation
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
US5684169A (en) * 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use
US5959089A (en) * 1993-07-19 1999-09-28 Hannessian; Stephen Amino-cyclodextrin syntheses
FR2715307B1 (fr) * 1994-01-25 1996-04-05 Commissariat Energie Atomique Procédé de solubilisation dans un milieu aqueux d'agents antitumoraux de la famille du taxol, et cyclodextrines ramifiées utilisables pour cette solubilisation.
FR2716200B1 (fr) * 1994-02-11 1996-04-26 Commissariat Energie Atomique Procédé de préparation de cyclomaltooligosaccharides ramifiés, en particulier de cyclodextrines ramifiées.
FR2746103B1 (fr) * 1996-03-14 1998-07-24 Thioureido-cyclodextrines, utilisables en particulier pour solubiliser des agents antitumoraux et antiparasitaires et leurs procedes de preparation
US5770645A (en) * 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US6157642A (en) 1997-10-14 2000-12-05 Teledesic Llc Coding system and method for low-earth orbit satellite data communication
FI980489A7 (fi) * 1998-03-04 1999-09-05 Alexei Radievich Khomutov Syklodekstriinien uudet johdannaiset

Also Published As

Publication number Publication date
DE602004025213D1 (de) 2010-03-11
JP5054970B2 (ja) 2012-10-24
ATE455795T1 (de) 2010-02-15
US7632941B2 (en) 2009-12-15
US8440814B2 (en) 2013-05-14
US20090264540A1 (en) 2009-10-22
FR2852959A1 (fr) 2004-10-01
WO2004087768A1 (fr) 2004-10-14
JP2006521440A (ja) 2006-09-21
CA2520391A1 (fr) 2004-10-14
EP1608687A1 (fr) 2005-12-28
US20070167401A1 (en) 2007-07-19
ES2338558T3 (es) 2010-05-10
CA2520391C (fr) 2012-11-20
EP1608687B1 (fr) 2010-01-20

Similar Documents

Publication Publication Date Title
MA29870B1 (fr) Nouveaux dérivés de 1-azabicycloalkyles dans le traitement de troubles psychotiques et neurodégénératifs
TW200626579A (en) Inhibitors of the interaction between MDM2 and p53
SE9904652D0 (sv) Novel Compounds
TR200201187T2 (tr) Ters transkriptazın inhibitörleri olarak benzofenonlar
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
ATE309237T1 (de) Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
NO20081554L (no) Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav
ATE433447T1 (de) Pyrimiidinverbindungen
IS6658A (is) Ný efnasambönd
IS6852A (is) Efnasambönd
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
TW200508228A (en) Biaryl heterocyclic compounds and methods of making and using the same
PT1474425E (pt) Desazapurinas e sua utilizacao
IS7965A (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
PT1506185E (pt) Compostos novos e sua utilizacao
ATE407128T1 (de) Phenylsubstituierte 5,6-dihydro-pyron-derivate als pestizide und herbizide
DE60004005D1 (de) Zusammensetzungen für Beschichtungen auf Basis von (Per)fluoropolyethern
ATE538124T1 (de) Imidazokondensierte tricyclische verbindungen auf thiazoloä4,5-büpyridin-basis und pharmazeutische zusammensetzungen damit
ATE431328T1 (de) Photopolymerisierbare verbindungen
DE602004025213D1 (de) Neue cyclodextrinderivate, herstellungsverfahren dafür und verwendung davon zur solubilisierung von pharmakologisch wirksamen substanzen
TW200503703A (en) Pharmaceutical compositions
SE0303090D0 (sv) Novel compounds
NO20063293L (no) Farmasoytiske forbindelser
DE50311756D1 (de) Mikrobizide oxathiincarboxamide

Legal Events

Date Code Title Description
TQ Partial transmission of property
ST Notification of lapse

Effective date: 20141128